Comparison of a new enzymatic assay with a high‐performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients
Benoit Blanchet, Fabrice Taieb, Filomena Conti, Halim Abbas, Idrissa Seydi, Laura Harcouet, Alain Dauphin, Yvon Calmus, Michel Tod – 24 November 2008 – Mycophenolic acid (MPA) is used to prevent graft rejection. The methods used for determining the plasma MPA concentration in liver transplant recipients are the enzyme‐multiplied immunoassay technique (EMIT), high‐performance liquid chromatography with ultraviolet detection (HPLC‐UV), and most recently mass spectrometry. EMIT has been reported to overestimate the MPA concentration by 30% to 35% in comparison with HPLC‐UV.